Investors weighing two of America's most established life insurers often arrive at a familiar question: which stock better balances growth, income, and risk in the current market? MetLife, Inc. (MET) and Prudential Financial, Inc. (PRU) both sit in the Insurance–Life sector, yet their growth drivers, geographic footprints, and valuation profiles differ meaningfully. This stock comparison is relevant for dividend-oriented investors, value seekers, and traders tracking relative performance and market positioning among financial heavyweights. By examining recent performance, catalysts, and risk factors, this article provides a clear, data-grounded view of how these two names currently stack up against one another.
MetLife, Inc. is a New York–based financial services company providing insurance, annuities, employee benefits, and asset management worldwide. It operates across six segments, including Group Benefits, Retirement and Income Solutions (RIS), Asia, Latin America, and EMEA (Europe, the Middle East, and Africa). This diversification has supported consistent results, with recent quarters showing adjusted earnings growth driven by favorable underwriting, higher net investment income, and broad volume gains.
In recent weeks, MET has traded near the upper end of its 52-week range, reflecting strengthening investor sentiment. Its most recent quarterly adjusted return on equity (ROE) reached the top of the company's 15%–17% target range, a sign of improving profitability. Strong contributions from Group Benefits and Asia, alongside a growing pension risk transfer (PRT) pipeline, have reinforced the growth narrative. Analysts have responded by raising price targets, and the consensus rating on the stock is a Buy. The company's global reach and capital-return programs, including buybacks and dividends, have kept MET firmly on the radar of long-term and income-oriented investors alike.
Prudential Financial, Inc. is a Newark, New Jersey–based insurer and asset manager with a significant presence in the United States, Japan, and select international markets. Its business spans PGIM (Prudential Global Investment Management), Retirement Strategies, Group Insurance, Individual Life, and International Businesses. PGIM is a notable differentiator, managing well over $1 trillion in assets under management (AUM), which positions PRU as both an insurer and a premier active global investment manager.
Recent market activity for PRU has been shaped by mixed signals. The company has reported solid adjusted operating income growth, aided by higher net investment spreads and new business growth in Brazil. However, a sales suspension ordered by Japanese regulators on certain products has created a near-term earnings headwind, with management citing a measurable impact across recent and upcoming quarters. This has tempered momentum relative to peers. On the positive side, PRU's dividend yield near 5% and a lower trailing P/E multiple make it an attractive candidate for value and income-focused investors, even as its share price sits below its 52-week high.
For traders seeking a data-driven edge, Tickeron's Trending AI Robots page offers a curated selection of automated strategies. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only those best suited to current market conditions earn a place in this featured section. Each robot has its own trading style, strategy, timeframe, performance history, and set of tickers it monitors, giving users the flexibility to match a bot to their objectives. Whether you are focused on short-term momentum or longer-term trend-following, exploring the Trending AI Robots can help you identify automated tools aligned with today's market environment.
The two companies diverge most sharply on geographic exposure and growth momentum. MET leans on a diversified global footprint, with Asia and Latin America providing incremental volume growth that has supported earnings consistency. PRU, by contrast, is more concentrated in the U.S. and Japan, and its international segment has recently faced regulatory friction that MET has not.
From a valuation standpoint, PRU trades at a lower trailing P/E and offers a substantially higher dividend yield, appealing to income investors. MET carries a higher multiple but pairs it with faster recent earnings expansion and stronger year-to-date relative performance. On risk factors, MET's diversified model reduces single-market dependence, while PRU's Japan sales suspension introduces a specific, identifiable near-term drag. In terms of sector exposure, both remain sensitive to interest rates and credit conditions, but PRU's asset-management arm, PGIM, adds a fee-based revenue stream that diversifies its earnings mix beyond traditional underwriting.
Based on observable factors such as trend consistency, stability, and relative positioning, Tickeron's AI would likely favor MET in the current environment. The stock's steadier upward trend, broad-based segment growth, and comparatively cleaner catalyst profile contrast with the specific regulatory headwinds weighing on PRU. That said, the assessment is probabilistic rather than definitive: PRU's higher yield and lower valuation could appeal under different market conditions, particularly if its Japan issues are resolved faster than expected. The relative balance of trend and catalysts currently tilts toward MET, while PRU remains a credible value alternative for income-oriented portfolios.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 26 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MET as a result. In 54 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for MET turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 32 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 23 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.315) is slightly higher than the industry average of (1.316). P/E Ratio (19.008) is within average values for comparable stocks, (19.663). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
PRU saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 57 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 61%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PRU's RSI Indicator exited the oversold zone, 13 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for PRU just turned positive on October 15, 2026. Looking at past instances where PRU's MACD turned positive, the stock continued to rise in 25 of 45 cases over the following month. The odds of a continued upward trend are 56%.
Following a +2.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRU advanced for three days, in 209 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 65 cases where PRU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.
PRU moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
PRU broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PRU entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.259) is normal, around the industry mean (1.316). P/E Ratio (10.389) is within average values for comparable stocks, (19.663). Projected Growth (PEG Ratio) (0.674) is also within normal values, averaging (0.463). Dividend Yield (0.049) settles around the average of (0.047) among similar stocks. P/S Ratio (0.632) is also within normal values, averaging (1.303).
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. PRU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET | PRU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 38 | 74 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 22 | 45 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 23 | 47 | |
P/E GROWTH RATING 1..100 | 11 | 90 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRU's Valuation (30) in the Financial Conglomerates industry is in the same range as MET (54) in the Life Or Health Insurance industry. This means that PRU’s stock grew similarly to MET’s over the last 12 months.
MET's Profit vs Risk Rating (22) in the Life Or Health Insurance industry is in the same range as PRU (45) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as PRU (100) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's Price Growth Rating (23) in the Life Or Health Insurance industry is in the same range as PRU (47) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's P/E Growth Rating (11) in the Life Or Health Insurance industry is significantly better than the same rating for PRU (90) in the Financial Conglomerates industry. This means that MET’s stock grew significantly faster than PRU’s over the last 12 months.
| MET | PRU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 55% | 1 day ago 59% |
| Stochastic ODDS (%) | 1 day ago 56% | 1 day ago 60% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 56% |
| TrendWeek ODDS (%) | 1 day ago 55% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 55% |
| Advances ODDS (%) | 6 days ago 65% | 13 days ago 60% |
| Declines ODDS (%) | 28 days ago 52% | 9 days ago 56% |
| BollingerBands ODDS (%) | 1 day ago 53% | 1 day ago 50% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 55% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while PRU’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 3 TA indicator(s) are bullish while PRU’s TA Score has 4 bullish TA indicator(s).
MET (@Life/Health Insurance) experienced а -1.19% price change this week, while PRU (@Life/Health Insurance) price change was -0.05% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -1.29%. For the same industry, the average monthly price growth was -3.69%, and the average quarterly price growth was -4.87%.
MET is expected to report earnings on Nov 04, 2026.
PRU is expected to report earnings on Nov 03, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
A.I.dvisor indicates that over the last year, PRU has been closely correlated with MET. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRU jumps, then MET could also see price increases.